On the other hand, somatic mutations seem useful in guiding the intensity of the conditioning regimen or at least avoiding circumstances where the increased intensity is ineffective—thus, given the lack of difference in outcomes between MAC and RIC regimens in TP53-mutated MDS, it seems reasonable to proceed with RIC, provided that other patient and disease factors have been taken into consideration. Here, TP53 is linked to myelodysplastic syndrome.